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The emergence of carotid angioplasty and stent-
ing in recent years has called into question the best
management of carotid restenosis after carotid
endarterectomy.1 Previous reports have defined the
pathophysiology of recurrent stenosis, and it is wide-
ly acknowledged that carotid restenosis during the
first 2 to 3 years after carotid endarterectomy usually
involves the process of myointimal hyperplasia,
whereas beyond 3 years, recurrent atherosclerosis is
the main contributing factor.2-4 Common percep-
tions regarding operations for recurrent carotid
stenosis are that the operations are more technically
difficult than primary endarterectomy, that they carry
a higher risk of nerve injury, and that they are associ-
ated with a higher perioperative stroke and mortality
rate than primary endarterectomy. These notions
have contributed to recent changes in management
strategies for carotid restenosis. A number of clinical
trials are underway to evaluate the effectiveness and
safety of carotid angioplasty and stenting for primary
and recurrent carotid artery stenosis.
This report describes the treatment of carotid
restenosis in 40 consecutive patients by vascular
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surgery faculty at a single academic institution. The
results are compared with the outcomes of all the
patients who underwent primary carotid endarterec-
tomy in the same institution during the same period.
METHODS
The medical records of all patients who under-
went carotid operations in a 5-year period by vascu-
lar surgery faculty were retrospectively reviewed.
Every consecutive carotid operation, as determined
by the hospital’s quality control oversight commit-
tee, was reviewed. No cases were missed or lost. The
patient demographic characteristics, risk factors, and
details of primary operations were evaluated for all
the carotid operations performed.
The assessment of operations for carotid resteno-
sis and outcomes included a review of preoperative
duplex scanning and angiographic studies, operative
reports, hospital charts, and clinic records. Hospital
cost information represented direct and indirect costs
of the patient’s care, excluding physician fees.
Charges billed to patients or third party payers were
not included.
Carotid duplex scanning studies were performed
with an Acuson (Mountain View, Calif) 5.0 MHz
multihertz imaging transducer, a 3.5 MHz Doppler
scan frequency, and a consistent 60-degree angle of
insonation. A high-grade stenosis was defined as a
‡ 80% reduction in internal carotid artery (ICA) diam-
eter. The corresponding blood flow velocities gener-
ally included an ICA peak systolic velocity of 3.3 m/s
or higher and an ICA end diastolic velocity of 1.3
m/s or higher. An ICA/common carotid artery peak
systolic ratio of 3.8 or higher also corresponded to a
‡ 80% ICA stenosis. These criteria were verified by
means of angiography for accreditation by the
Intersocietal Commission for the Accreditation of
Vascular Laboratories. The angiographic criteria were
outlined in the North American Symptomatic Carotid
Endarterectomy Trial.5
The persistence or progression of a high-grade
carotid stenosis was defined as a ‡ 80% stenosis on
two or more consecutive duplex scanning studies
performed at least 1 month apart. The operations
were performed by five vascular surgeons. The
patients who underwent operations for asympto-
matic recurrent carotid disease all had a high-grade
internal carotid stenosis >80% as determined with
color-flow duplex scanning, arteriography, or both.
Intraoperative assessment of carotid arteries after
primary endarterectomy and reoperative surgery
involved assessment with a Doppler scan probe. If
flow signals in the common, internal, or external
carotid arteries were qualitatively abnormal or if there
were other reasons for concern, carotid angiography
was performed.
There was no strict postoperative surveillance pro-
tocol. However, the patients were typically seen within
2 weeks from the time of surgery. Surveillance carotid
duplex scan studies were performed at 1 month, 3
months, and 6 months after surgery. At the discretion
of the attending surgeon, some patients underwent
repeat duplex scan studies at 3-month intervals for the
first 1 to 2 years after surgery, whereas other patients
underwent studies at 6-month intervals after the 6th
postoperative month. Most patients had yearly studies
after 2 years if no recurrent stenosis was detected.
When patients were found to have a recurrent stenosis,
more frequent studies were sometimes conducted until
reoperative surgery was performed, disease progression
was stopped, or regression of the stenosis occurred.
Carotid angiography was performed in most cases of
early recurrence or when duplex scanning failed to
show the full extent of recurrent disease.
Table I. Patient characteristics




Age (years) 72 ± 8 (range, 42 to 93)
Risk factors*
Hypertension 289 (82)
Significant smoking history 264 (75)
Hyperlipidemia 254 (72)
Coronary artery disease 190 (54)
Diabetes mellitus 109 (31)
*No significant difference between primary and reoperative
groups.
Table II. Indications for operations
No. of 
patients (%)
Indications for primary carotid endarterectomy:
Asymptomatic high-grade stenosis 147 (42)
Transient ischemic attacks or amaurosis fugax 122 (35)
Stroke 32 (9)
Global or vertebrobasilar symptoms 49 (14)
Total 350
Operative indications for carotid restenosis:
Asymptomatic high-grade stenosis 20 (50)
Transient ischemic attacks or amaurosis fugax 15 (38)
Stroke 3 (7)
Global or vertebrobasilar symptoms 2 (5)
Total 40
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RESULTS
The full-time vascular surgical faculty at Stanford
University Medical Center performed 350 primary
carotid endarterectomies and 40 operations for
carotid restenosis between September 1993 and July
1998. These 390 operations were performed on 352
patients (205 men and 147 women). Ages ranged
from 42 to 93 years, with a mean age of 72 years. Of
the 40 patients who underwent treatment for recur-
rent disease, 24 had their primary operations per-
formed elsewhere. The most common associated
risk factors in the overall group were hypertension
(82%), significant smoking history (75%), hyperlipi-
demia (72%), coronary artery disease (54%), and
diabetes mellitus (31%; Table I).
Primary carotid endarterectomy. The indica-
tions for primary carotid endarterectomy and opera-
tions for carotid restenosis were similar, as outlined
in Table II. Primary carotid endarterectomy was per-
formed for asymptomatic high-grade stenosis (42%),
amaurosis fugax and transient ischemic symptoms
(35%), global symptoms (14%), and previous stroke
(9%).
No procedure-related deaths occurred in the pri-
mary endarterectomy group during the same 5-year
period. The overall stroke rate for primary carotid
endarterectomy was 1.1% (three postoperative strokes,
one preoperative stroke after angiography). One
patient had a postoperative transient ischemic attack.
No patients in this group had permanent cranial nerve
deficits. Five patients required return trips to the oper-
ating room for evacuation of neck hematomas.
The mean length of stay in the primary carotid
endarterectomy group was 2.6 ± 1.1 days (range, 1
to 11 days), and the mean hospital cost was $9700.
Forty percent of patients underwent cerebral
angiography.
Reoperation for recurrent stenosis. Operative
indications for recurrent carotid stenosis included
asymptomatic high-grade stenosis (50%), transient
ischemic attacks (28%), and amaurosis fugax (10%).
Three of the 40 patients for redo operation had a
high-grade stenosis associated with pulsatile tinnitus,
and three had a history of ipsilateral stroke.
The type of closure used at the first carotid oper-
ation was primary closure in 72% of the cases and
patch closure in 23% of the cases. Carotid recon-
struction with an interposition graft was performed
in 5% of the redo cases.
Preoperative imaging for patients with recurrent
carotid stenosis (n = 40) included only carotid
duplex scanning in 12%, both carotid duplex scan-
ning and angiography in 60%, and only angiography
in 28%. On the basis of carotid duplex scan imaging
alone, of the patients who underwent operations for
recurrent stenosis, 21 (72%) had carotid artery
diameter stenoses ‡ 80% and all patients with
stenoses <70% had associated ulcers. The mean ipsi-
lateral carotid artery diameter stenosis as determined
by means of angiography was 82% ± 15%. Three
patients had high-grade stenoses associated with
contralateral occlusions.
The time from primary operation to reoperation
for recurrent carotid stenosis ranged from 5 to 252
months, with a mean time interval of 72 months, as
indicated in Table III. Late recurrent stenosis (‡ 2
years) was the most common and occurred in 23
cases (58%), whereas early recurrent stenosis
occurred in 17 cases (42%).
The operations performed for carotid restenosis
are listed in Table IV. The most common operation
was carotid artery reconstruction with an interposi-
tion graft in 50% of the patients. A polytetrafluo-
roethylene (PTFE) graft was used in 12 cases (30%),
and a saphenous vein graft was used in eight cases
(20%). A saphenous vein, Dacron graft, or PTFE
patch was used in combination with carotid
endarterectomy in 13 cases (32%). Three patients
had patch angioplasty alone. Carotid endarterecto-
my with primary closure was performed in two
Table III. Time from primary carotid endarterec-
tomy to reoperation
No. of patients (%)
Early recurrent stenosis (<24 months) 17 (42)
Late recurrent stenosis (‡ 24 months) 23 (58)
Mean time from primary endarterectomy 72 ± 64
to reoperation (months): (range, 5 to 252)





Endarterectomy with patch 13 (32)
Endarterectomy with primary closure 2 (5)
Patch angioplasty alone 3 (8)
Interposition graft 20 (50)
External carotid to internal carotid transposition 2 (5)
Use of shunt
Shunt used 33 (82)
No shunt used 7 (18)
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instances of late recurrent stenosis. Two patients
underwent internal to external carotid artery trans-
position. Shunts were used in 82% of the cases,
according to surgeon preference and the perceived
adequacy of cerebral perfusion during clamping.
In the carotid restenosis group at operation, 45%
of recurrent disease involved the carotid bifurcation,
40% involved only the ICA, and 12% involved only
the common carotid artery. A vein graft stenosis was
present in one case (Table V). In the patients who
had early recurrent stenosis (<2 years after primary
endarterectomy; n = 17), myointimal hyperplasia
was found in every case. In one instance of early
restenosis, a residual stenosis from the primary
endarterectomy and development of myointimal
hyperplasia contributed to a 95% ICA restenosis. In
the late restenosis group ( ‡ 2 years after primary
operation; n = 23), 65% of stenoses contained only
atheromatous material, 31% contained elements of
both atheroma and myointimal hyperplasia, and one
consisted only of myointimal hyperplasia.
The operations for recurrent carotid stenosis
usually necessitated more operative time to dissect
the artery from the surrounding scar tissue while
carefully avoiding injury to adjacent structures.
Carotid reconstruction with interposition vein grafts
necessitated more time than did redo carotid
endarterectomy. Overall, the redo operations neces-
sitated less than 1 hour more than the 2 to 3 hours
for a typical primary carotid endarterectomy.
Complications that occurred in patients who
underwent operations for recurrent carotid stenosis
are listed in Table VI. No patient had a stroke or a
transient ischemic attack or died. No patient had a
permanent cranial nerve deficit. The most common
complications were cardiac related. One patient had
myocardial infarction associated with tachyarrhyth-
mia and moderate cardiac enzyme elevations but no
chest pain, hypotension, or congestive heart failure.
Two additional patients had congestive heart failure
that prolonged the hospital stay 3 days in one case
and 7 days in the other. Transient cranial nerve dys-
function occurred in three cases and included symp-
toms of hoarseness in two instances, both of which
resolved by the 4th postoperative day, and difficulty
swallowing in one patient, which resolved by the
2nd postoperative day. One patient had Horner’s
syndrome, which resolved by the 3rd postoperative
month.
Follow-up data were available for 38 of the 40
patients who underwent operations for carotid
restenosis. The duration of the follow-up period
ranged from 1 to 52 months, with a mean of 14
months. Thirty-four patients (85%) underwent fol-
low-up examination with carotid duplex scanning,
four patients (10%) underwent follow-up examina-
tion without carotid duplex scanning, and two
patients (5%) did not undergo follow-up examina-
tion. Of the 34 patients who underwent follow-up
duplex scan studies, 82% had widely patent ipsilater-
al carotid arteries without restenosis. One patient
who underwent a redo carotid endarterectomy and
Dacron patch angioplasty had an asymptomatic 70%
to 79% residual stenosis that was detected on the ini-
tial postoperative duplex scan study. Four patients
who underwent carotid reconstruction with interpo-
sition vein grafts had severe stenoses (90% to 99%)
develop between the 1st and 12th postoperative
months. These patients all had patent vein grafts
without stenosis shown on the first postoperative
duplex scan study and stenosis of vein grafts shown
on subsequent studies. One preocclusive stenosis
was treated with percutaneous transluminal angio-
plasty without placement of a stent. Initially, the
stenosis was reduced to 50% by means of angio-
graphic measurements. Six months later, color-flow
duplex scan results revealed recurrence of the steno-
sis to the 90% to 99% range. Another patient with a
severe vein graft restenosis went on have the carotid
artery occlude between the 1st and 3rd postopera-
Table V. Location and nature of recurrent stenosis
No. of patients (%)
Location of stenosis (n = 40):
CCA and ICA (± ECA) 18 (45)
ICA only 16 (40)
CCA only 5 (12)
Vein graft stenosis 1 (3)
Stenosis composition (n = 40): Myointimal hyperplasia only Myointimal hyperplasia + athero Athero only
Restenosis <2 years after CEA (n = 17) 16 (94) 1 (6) 0
Restenosis ‡ 2 years after CEA (n = 23) 1 (4) 7 (31) 15 (65)
CCA, Common carotid artery; ICA, internal carotid artery; ECA, external carotid artery; CEA, carotid endarterectomy.
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tive months. The other three severe vein graft
stenoses have remained patent at their latest duplex
scan evaluations at 12, 19, and 39 months. These
patients have undergone treatment with therapeutic
warfarin and have not had any strokes or transient
ischemic symptoms.
The mean length of stay in the redo group was 2.6
± 1.5 days (range, 1 to 7 days). The mean hospital cost
was $13,700. The higher hospital costs in the redo
group were accounted for by the cerebral angiography
that was performed in 90% of the redo cases as com-
pared with 40% of the primary endarterectomy cases.
The mean hospital cost for cerebral angiography was
$3500.
DISCUSSION
The procedure-related stroke-death rate after
reoperation for carotid restenosis in this series was
0%. There were no increases in complications,
lengths of stay, or surgery-related costs. These
results compare favorably with the results of prima-
ry carotid endarterectomy, which has been estab-
lished with prospective randomized trials as the stan-
dard of care for patients with severe symptomatic
and asymptomatic carotid stenosis.6
Previous reports have addressed the pathophysi-
ology and natural history of carotid restenosis.2-4
Mackey7 studied the natural history of recurrent
carotid stenosis in 688 patients. Five percent of the
patients had strokes more than 30 days after carotid
endarterectomy. The patients who had strokes with-
in 36 months after primary carotid endarterectomy
were less likely to have restenosis than were the
patients who had strokes more than 36 months after
endarterectomy (51% vs 31%). This finding suggest-
ed that early restenosis was associated with a lower
risk of stroke than was late restenosis.
A significant finding of the Aymptomatic
Carotid Atherosclerosis Study (ACAS) was the inci-
dence of carotid restenosis after carotid endarterec-
tomy for asymptomatic disease.8 Patients who
underwent carotid endarterectomy for a primary
carotid stenosis >60% had a 14% cumulative inci-
dence of residual and recurrent stenosis (residual
stenosis, 4%; recurrent stenosis, 10%).9 Strandness10
found regression of lesions in some patients but a
persistent carotid restenosis rate of 21%.
Operative techniques and risk factors that may
decrease the likelihood of carotid restensosis have
been identified. In the ACAS, patch angioplasty clo-
sure and placement of distal tacking sutures were
each associated with a decrease in carotid resteno-
sis.9 Intraoperative duplex scanning may reduce the
incidence of residual carotid stenosis but not the
incidence of recurrent stenosis.11 Patient risk factors
that may increase the likelihood of carotid restenosis
include age of more than 65 years and cigarette
smoking.12
Consistent with previous reports, 95% of patients
in this series who had recurrent stenosis develop
within 2 years had lesions that consisted entirely of
myointimal hyperplasia.4 At reoperation, these
lesions appeared smooth and pearly white. Either
patch angioploasty or carotid reconstruction with an
interposition graft is usually appropriate in such
cases. Carotid restenosis that arises after 4 years is
more likely the result of recurrent atherosclerosis.
Patients with these lesions tend to have a higher inci-
dence of embolization related complications—tran-
sient ischemic attacks, amaurosis fugax, and stroke.
In these cases, redo carotid endarterectomy in con-
junction with patch angioplasty is often the proce-
dure of choice. Fig 1 shows a magnetic resonance
angiogram of a focal high-grade stenosis at the
carotid bifurcation. Recurrent atherosclerosis, fre-
quently seen in late restenosis, may have an ulcera-
tive, irregular pattern (Fig 2).
In 1976, Stoney and String13 reported that 1.6%
Table VI. Results of primary carotid endarterectomy and reoperative carotid surgery
Primary carotid endarterectomy (n = 350) Reoperative carotid surgery (n = 40)
Death 0 0
Stroke 4 (1.1%) 0
Transient ischemic attacks 1 (0.3%) 0
Transient cranial nerve dysfunction (<7 days) — 3 (7.2%)
Myocardial infarction — 1 (2.5%)
Congestive heart failure — 2 (5.0%)
Horner’s syndrome — 1 (2.5%)
Reoperation for evacuation of neck hematoma 5 (1.4%) 0
Stroke-death rate 1.1% 0
Permanent cranial nerve deficit 0 0
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of patients who underwent primary carotid endart-
erectomy later required reoperation on the same
artery. Little controversy exists regarding reoperation
for symptomatic carotid restenosis. However, selec-
tion criteria have not been firmly established for
reoperative carotid surgery in patients who are
asymptomatic. Bernstein et al14 reported the results
of 566 consecutive carotid endarterectomies. Follow-
up duplex scan examination revealed a >50% resteno-
sis in 10.1% of arteries, including eight carotid occlu-
sions. Interestingly, their results suggested that
patients with recurrent carotid stenosis had a better
life expectancy and a higher likelihood of remaining
stroke free than did those patients who did not have
recurrent stenosis after carotid endarterectomy.
An asymptomatic recurrent carotid stenosis
>80% presents a management dilemma. Healy et al15
showed that a stenosis >80% may progress to occlu-
sion of the carotid artery, an event that carries a 25%
chance of completed stroke. The present series
shows that the risk of reoperative carotid surgery is
no higher than the risk of primary carotid
endarterectomy. Therefore, reoperative surgery
should be considered for the patient who is asymp-
tomatic and who has a high-grade carotid stenosis
that is believed to be at risk for occlusion.
The overall stroke rates in this series for primary
carotid endarterectomy (1.1%) and recurrent steno-
sis (0%) were low, and no deaths occurred in either
group. The low stroke rates may be related to care-
ful operative technique to avoid embolization and
attention to ensure adequate cerebral perfusion.
Intraluminal shunts were used in more than 80% of
the operations in both groups. Guidelines that
define acceptable stroke-death rates for carotid
surgery have been suggested. A 1995 American
Heart Association consenses statement defined
acceptable stroke-death rates for carotid endarterec-
Fig 2. Carotid angiogram reveals ulcerated stenosis
involving proximal internal carotid artery in patient with
transient ischemic symptoms referable to ipsilateral cere-
bral hemisphere.
Fig 1. Magnetic resonance angiogram shows focal high-
grade stenosis at carotid bifurcation in patient who was
asymtomatic 2 years after ipsilateral carotid endarterecto-
my. Carotid duplex ultrasound scan results revealed fre-
quency criteria consistent with 90% to 99% stenosis of
proximal internal carotid artery.
tomy as less than 6% for patients who are sympto-
matic with stenoses >70% and as less than 3% for
patients who are asymptomatic with stenoses >60%.
The formation of these standards for primary
endarterectomy was made mainly on the basis of
results from the North American Symptomatic
Carotid Endarterectomy Trial and the ACAS.5-7 The
American Heart Association Stroke Council consen-
sus statement of 1989 set the upper limit of accept-
able stroke-death rate for operative treatment of
recurrent carotid stenosis at 10%.16 Little and
Meyer17 reported a stroke-death rate of 8.5% for
113 cases of recurrent carotid stenosis treated surgi-
cally at the Mayo Clinic, whereas Mansour et al18
reported a lower stroke-death rate of 4.8%. Similar
to the results in this series, Ballinger et al19 reported
the outcomes of 67 patients who underwent surgi-
cal treatment for recurrent carotid stenosis in an 11-
year period. The 30-day overall stroke-death rate
was 2.8%, which is well within acceptable limits for
primary carotid endarterectomy. A metanalysis of all
series reporting reoperative carotid surgery is of lim-
ited value because study parameters, such as techni-
cal aspects of surgery and surgeon experience, can-
not be standardized.
The incidence of transient cranial nerve dysfunc-
tion lasting less than 1 week was 8% in this series.
There were no permanent cranial nerve deficits.
Similarly, Mansour et al18 reported an overall tran-
sient or permanent cranial nerve dysfunction of 7%.
The incidence of cranial nerve palsies has been
reported as high as 20%; however, most have been
transient.6 To minimize the risk of stroke and cranial
nerve injury, most authorities emphasize that reop-
erative carotid surgery should only be performed by
surgeons with extensive experience in dealing with
carotid restenosis. Careful patient selection and risk
assessment are also critical.6,9,20
Four of the eight saphenous vein interposition
grafts in this series developed severe stenoses
between the 1st and 12th postoperative months, and
one of these occluded before the 3rd postoperative
month. Therefore, the late failure rate for saphenous
vein grafts in this series was 50%. Likewise, Rockman
et al21 recently reported the results of 82 carotid
reoperations in 74 patients. Three patients had
strokes, and carotid arteries reconstructed with
interposition vein grafts had a significantly higher
rate of late failure (stroke, restenosis, or occlusion)
than those that used prosthetic material (20.0% vs
2.3%; P = .002). Because the number of vein graft
reconstructions in this series was small, we cannot
draw firm conclusions regarding the appropriateness
of vein grafts for carotid reconstruction. However,
we do conclude that carotid reconstructions with
PTFE interposition grafts have a favorable outcome
in our experience.
The safety and benefit of new catheter-based
therapies for treatment of carotid stenosis should be
evaluated and judged against standard reoperative
therapy. CREST, the Carotid Revascularization:
Endarterectomy versus Stent Trial, is a prospective
multi-center clinical study currently underway to
compare the results of operative and endovascular
management of carotid stenosis.22,23 During the
period from 1989 through 1997, recurrent carotid
stenosis was managed with reoperation in 16 cases
and with carotid angioplasty and stenting in 15
cases. Patients who had recurrent stenosis within 18
months after primary carotid endarterectomy were
identified for carotid angioplasty and stenting. In
both the reoperative and angioplasty-stent groups,
no strokes or postprocedure deaths occurred. The
reoperative group had no reported complications.
Duplex ultrasound scan results in the angioplasty-
stent group revealed no restenosis or stent occlu-
sions with a mean follow-up period of 7 months.24
A larger series reported by Robbin et al25
involved duplex ultrasound scan studies on 87
carotid arteries immediately after carotid angioplasty
and stenting and on 83 carotid arteries at various
time intervals, with a mean interval of 7 months
postprocedure. One stent occlusion and one stent
collapse were detected, and a 63% recurrent stenosis
was detected in one patient. Despite good short-
term success, the authors were unable to present
convincing long-term data that proved efficacy and
safety compared with operative management.
Serious complications that have resulted from
carotid angioplasty and stenting for primary carotid
artery stenosis and restensosis include carotid dissec-
tion and acute occlusion,26 stent deformation,27
stroke caused by air embolism,28 transient ischemic
attack,29 and progressive stenosis that necessitated
operation.30,31 Bergeron et al26 reported a 33% neu-
rologic complication rate in 17 patients who under-
went carotid angioplasty without stent placement for
treatment of carotid restenosis. A 21% neurologic
complication rate was reported by Vozzi et al,32 who
described 24 carotid angioplasty and stenting proce-
dures in 22 patients, 12 of whom were asympto-
matic. Three patients had seizures during the proce-
dure, and two patients had strokes, one of whom
died as a result. The durability of carotid angioplas-
ty and stenting in cases of “technical success” is also
questionable. Mathur et al28 reported a 16% inci-
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dence of Palmaz stent collapse in cervical carotid
arteries by 6 months postprocedure.
Early carotid restenosis is associated with myoin-
timal hyperplasia at the endarterectomy site, and late
recurrent stenosis is related more to the develop-
ment or progression of new atheromatous plaque.
We agree with previous authors who have recom-
mended observation of asymptomatic recurrent
carotid stenoses that are not high grade (<80%
artery diameter reduction) and reoperation for
symptomatic or high-grade lesions that are believed
to be at risk for carotid occlusion. Surgical manage-
ment of recurrent carotid stenosis can be as safe as
primary carotid endarterectomy with sound clinical
decision making, strategic preoperative planning,
and careful operative technique. Vein interposition
grafts may be prone to a higher rate of failure than
PTFE grafts when used for carotid reconstruction.
The standard of care for the patient with recurrent
cartotid stenosis, who is deemed at risk for stroke,
should be evaluation and treatment by a vascular sur-
geon experienced in all aspects of carotid surgery.
Carotid angioplasty and stenting should be reserved
for patients enrolled in controlled clinical trials to
minimize patient risk and to help define its role in
treating carotid restenosis. Operation for recurrent
carotid stenosis should serve as the standard of treat-
ment. Angioplasty and stenting for recurrent carotid
stenosis should be compared with this standard.
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Dr Ralph B. Dilley. This was an excellent presentation
by Dr Hill and his colleagues and supports the work of
others in showing that reoperation for recurrent carotid
stenosis is safe and durable. In 40 patients undergoing
reoperation for recurrent stenosis, there were no deaths,
strokes, transient neurologic events, or permanent cranial
nerve deficits. Three patients had mild cranial nerve dys-
function, and one patient had a postoperative Horner’s
syndrome. These results are exemplary and mirror the
equally good results achieved in a group of patients under-
going primary carotid endarterectomy.
I have three questions for the authors:
First, several studies suggest that patients with early
recurrence (that is, those with myointimal hyperplasia) are
less prone to develop symptoms than are those with late
recurrence, where the pathology is generally caused by
recurrent atherosclerosis. In addition, other studies have
demonstrated occasional regression of these early lesions.
Therefore, in the 17 patients submitted for operation
because of an early recurrence, how many were sympto-
matic? What was the average time in this group from pri-
mary carotid endarterectomy to reoperation? What is your
overall incidence of significant early recurrent stenosis
(that is >50%), and have you documented any regression
of these lesions?
Second, when do you perform the first postoperative
duplex scan evaluation? Is it possible that some of the early
recurrences, in fact, could be residual disease? Do you use
intraoperative assessment to ensure a perfect result?
Although many surgeons do not do intraoperative assess-
ment, we continue to believe it is necessary and continue
to use intraoperative angiography because in our hands
this is the study that can be done most quickly.
Third, how do you decide whether to replace the
artery with a vein or prosthetic graft as opposed to per-
forming repeat endarterectomy with patch or patch angio-
plasty alone? In our more recent experience, we have tend-
ed to replace the segment with recurrent disease with a
vein interposition graft. We generally use a thigh saphe-
nous vein, which closely matches the size of the proximal
and distal carotid artery, and have not been impressed with
recurrent stenosis in this group. I was somewhat surprised
that four of your vein interposition grafts have shown
recurrent disease. Where are the recurrences, at the anas-
tomosis or in the body of the graft? And are you able to
characterize the nature of the obstruction?
Finally, a word about carotid stenting. We would cer-
tainly agree that there is a major effort by cardiologists to
recommend stents for carotid obstructive disease, particu-
larly recurrent carotid artery stenosis. I may be naive, but
it seems to me that if a patient develops recurrent carotid
stenosis in response to an operative procedure and his ves-
sels are prone to this response, they would equally respond
with further obstruction after placement of a stent, unless
a patch or interposition graft is placed. Secondly, although
it is difficult to be certain of the exact number of neuro-
logic complications associated with stent placement at the
carotid bifurcation, my best guess is that they occur at a
rate of 7% to 8%, and this is based on reviewing a number
of papers where stents have been placed. Now, not all of
these neurologic complications are serious, but in my view
a small stroke or a transient stroke is a significant event,
and I certainly would not want one myself. Although sev-
eral large scale studies that propose to compare stents with
carotid endarterectomy are under consideration, none yet
have been funded, and I believe there are many ethical
considerations to consider before wholeheartedly support-
ing such studies. It is important that we as surgeons con-
tinually track our own results and publish the excellent
results of reoperative carotid surgery, such as we have
heard today.
Thank you for allowing me to discuss this paper.
Dr Bradley B. Hill. Dr Dilley, thank you for raising
these important questions. Of the 17 patients who had
early recurrent stenosis, only three patients (18%) were
symptomatic. The remaining 14 patients (82%) had >80%
stenoses, most of which were progressive or high grade,
and there were concerns that these arteries might have
gone on to occlude without surgery. As you mentioned, a
significant percentage of early recurrent stenoses, perhaps
up to 30%, will undergo some degree of regression.
Consistent with this, we have documented regression of
early recurrent lesions in some instances. In general, we
recommend serial duplex scanning studies for recurrent
stenoses that are not high grade (<80%).
In this series, the mean time from primary carotid
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endarterectomy to reoperation in patients with early recur-
rent stenosis was 12 months (range, 5 to 21 months). Of the
390 carotid operations performed, 40 (10%) were redo pro-
cedures, and 22 of these patients had their primary
endarterectomies at another facility. Overall, only a fraction
(<5%) of redo operations were performed in patients whose
primary carotid endarterectomies were included in the 350
primary operations in the series. In my estimation, the inci-
dence of early recurrent stenosis after primary endarterecto-
my was consistent with previously published reports, approx-
imately 20% or so, and most of these restenoses were asymp-
tomatic, not high grade, and did not necessitate reoperation.
In answer to your second question about postopera-
tive duplex scan evaluation, we routinely perform the ini-
tial postoperative study within 4 to 6 weeks from the time
of surgery. Only one patient for redo surgery had a resid-
ual stenosis detected at the initial postoperative duplex
scan study, and this was a 60% asymptomatic stenosis in
the distal internal carotid artery. We routinely use a hand-
held pencil Doppler scan intraoperatively to assure paten-
cy of the artery, and we believe that this is adequate unless
we hear abnormal flow signals or have other reasons to
suspect a problem. We have occasionally used duplex
ultrasound scanning to evaluate the artery through the
open incision, and we have also performed carotid arteri-
ography on rare occasions.
Our decision to replace a diseased carotid artery with
an interposition graft as opposed to performing a redo
carotid endarterectomy or patch angioplasty alone is made
on the basis of a number of considerations. If the artery is
diffusely thickened without an endarterectomy plane or if
significant periarterial scar tissue is present, replacement
with an interposition graft may be easier and may lessen
the chances of cranial nerve injury. If the recurrent steno-
sis is late, the best option may be redo endarterectomy and
patch angioplasty. Intraoperative decision making is
important in these cases, and the best option may depend
on what is found at the time of surgery.
Of the 40 redo operations performed in this series,
eight involved carotid reconstructions with interposition
vein grafts. Four of the vein grafts developed recurrent
stenoses >90%, all of which were near or at the distal anas-
tamosis. One of these four late failures went on to occlude
without an associated stroke or other neurologic event.
Because the number of vein interposition grafts in this
series was small, we cannot make any definitive comments
regarding their use for carotid reconstruction other than
to say that our results with them have not been good.
Interestingly, 12 patients in this series underwent carotid
reconstruction with interposition PTFE grafts, and none
of these reconstructions occluded or developed a recur-
rent stenosis. Therefore, in our experience, PTFE has been
a good interposition graft for carotid reconstruction and
we usually prefer it over saphenous vein in these cases.
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